Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2009 1
2010 1
2011 1
2012 1
2015 2
2016 2
2018 1
2019 5
2020 3
2021 1
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Grade 2 Proctitis, CTCAE"
Page 1
ONE SHOT - single shot radiotherapy for localized prostate cancer: 18-month results of a single arm, multicenter phase I/II trial.
Zilli T, Franzese C, Guckenberger M, Giaj-Levra N, Mach N, Koutsouvelis N, Achard V, Mcdonald A, Alongi F, Scorsetti M, Constantin G, Bertaut A, Miralbell R. Zilli T, et al. Radiother Oncol. 2024 May;194:110181. doi: 10.1016/j.radonc.2024.110181. Epub 2024 Feb 24. Radiother Oncol. 2024. PMID: 38403022 Free article. Clinical Trial.
The worst GU toxicity was observed at day-5 after SBRT (42.5 % and 20 % with grade 1 and 2, respectively), returning to baseline at week-12 and month-6 (<3% with grade 2), with a 12 % grade 2 flare at month 18. Gl toxicity was mild in …
The worst GU toxicity was observed at day-5 after SBRT (42.5 % and 20 % with grade 1 and 2, respectively), returning to baseli …
Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future.
Spampinato S, Jensen NBK, Pötter R, Fokdal LU, Chargari C, Lindegaard JC, Schmid MP, Sturdza A, Jürgenliemk-Schulz IM, Mahantshetty U, Hoskin P, Segedin B, Rai B, Bruheim K, Wiebe E, Van der Steen-Banasik E, Cooper R, Van Limbergen E, Sundset M, Pieters BR, Lutgens LCHW, Tan LT, Villafranca E, Smet S, Jastaniyah N, Nout RA, Kirisits C, Chopra S, Kirchheiner K, Tanderup K, Embrace Collaborative Group. Spampinato S, et al. Int J Radiat Oncol Biol Phys. 2022 Mar 1;112(3):681-693. doi: 10.1016/j.ijrobp.2021.09.055. Epub 2021 Oct 20. Int J Radiat Oncol Biol Phys. 2022. PMID: 34678431
CTCAE severe grade (grade [G] 3) events were pooled according to the location in the GI tract (anus/rectum, sigmoid, and colon/small bowel). CTCAE G 2 and EORTC "very much" and "quite a bit" plus "very much" scores ( "quite a bit") were analyzed …
CTCAE severe grade (grade [G] 3) events were pooled according to the location in the GI tract (anus/rectum, sigmoid, an …
Iodine-125 seed brachytherapy for early stage prostate cancer: a single-institution review.
Zuber S, Weiß S, Baaske D, Schöpe M, Stevens S, Bodis S, Zwahlen DR. Zuber S, et al. Radiat Oncol. 2015 Feb 22;10:49. doi: 10.1186/s13014-015-0349-0. Radiat Oncol. 2015. PMID: 25880809 Free PMC article. Clinical Trial.
Biochemical failure was defined using the Phoenix definition (nadir + 2 ng/mL). Treatment-related morbidities, including urinary, rectal and sexual function, were measured, applying the International Prostate Symptom Score (IPSS), the 7-grade Quality of Life Scale ( …
Biochemical failure was defined using the Phoenix definition (nadir + 2 ng/mL). Treatment-related morbidities, including urinary, rec …
MRI- and PET-Guided Interstitial Brachytherapy for Postsurgical Vaginal Recurrences of Cervical Cancer: Results of Phase II Study.
Chopra S, Engineer R, Shah S, Shukla R, Dora T, Gupta P, Paul SN, Popat P, Swamidas J, Mahantshetty U, Varghese L, Gupta S, Rangrajan V, Shrivastava S. Chopra S, et al. Int J Radiat Oncol Biol Phys. 2020 Feb 1;106(2):310-319. doi: 10.1016/j.ijrobp.2019.10.037. Epub 2019 Nov 1. Int J Radiat Oncol Biol Phys. 2020. PMID: 31682968 Clinical Trial.
The mean gross tumor volume on T2 W MR was 20 (IQR 3.6-90) cc. The metabolic tumor volume was 15 (interquartile range [IQR] 2.1-56.1) cc. The median FLT volume was 10 (IQR 0-48) cc. A total of 8 patients had (18-)F F Miso uptake. ...At a median follow-up of 60 (5-93) month …
The mean gross tumor volume on T2 W MR was 20 (IQR 3.6-90) cc. The metabolic tumor volume was 15 (interquartile range [IQR] 2.1-56.1) …
Late toxicities of prostate cancer radiotherapy with and without hydrogel SpaceAOR insertion.
Te Velde BL, Westhuyzen J, Awad N, Wood M, Shakespeare TP. Te Velde BL, et al. J Med Imaging Radiat Oncol. 2019 Dec;63(6):836-841. doi: 10.1111/1754-9485.12945. Epub 2019 Sep 13. J Med Imaging Radiat Oncol. 2019. PMID: 31520465
RESULTS: The cumulative incidence of low-grade diarrhoea (G1) was significantly higher in the non-SpaceOAR group (21.4% vs 6.2%; P = 0.016). The cumulative incidence of proctitis (grades G1 and G2) was also higher in the non-SpaceOAR group (26.7% vs 9. …
RESULTS: The cumulative incidence of low-grade diarrhoea (G1) was significantly higher in the non-SpaceOAR group (21.4% vs 6.2 …
Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study.
Heumann P, Aguado-Barrera ME, Avuzzi B, Azria D, Briers E, Bultijnck R, Choudhury A, De Ruysscher D, Farcy-Jacquet MP, Fonteyne V, Gómez Caamaño A, Helmbold I, Johnson K, Kerns SL, Lambrecht M, Lingard Z, Rancati T, Rosenstein BS, Sperk E, Paul Symonds R, Talbot C, Valdagni R, Vega A, Veldeman L, Ward T, Webb A, West CM, Chang-Claude J, Seibold P; REQUITE Consortium. Heumann P, et al. Radiother Oncol. 2023 Jan;178:109426. doi: 10.1016/j.radonc.2022.11.015. Epub 2022 Nov 25. Radiother Oncol. 2023. PMID: 36442608 Free article.
To compare severity of grading between patients and healthcare professionals, percent agreement and deviations for each symptom were graphically depicted. ...RESULTS: The agreement for the 11 pelvic symptoms varied from very good (AC2 > 0.8: haematuria, rectal bleeding, …
To compare severity of grading between patients and healthcare professionals, percent agreement and deviations for each symptom were …
Timing of High-Dose-Rate Brachytherapy With External Beam Radiation Therapy in Patients With Intermediate- and High-Risk Localized Prostate Cancer and Its Effects on Toxicity and Quality of Life: A Randomized Controlled Trial (THEPCA).
Choudhury M, Thomas SS, Cain A, Palvai S, Nageshwaran S, Zhang J, Hayden K, Cain A, Hoskin P, Ahmed I. Choudhury M, et al. Int J Radiat Oncol Biol Phys. 2024 May 1;119(1):90-99. doi: 10.1016/j.ijrobp.2023.11.011. Epub 2023 Dec 30. Int J Radiat Oncol Biol Phys. 2024. PMID: 38163520 Clinical Trial.
METHODS AND MATERIALS: This was a single-center randomized trial in patients with intermediate- and high-risk localized prostate cancer who received HDR-BT before (Arm A) or after (Arm B) EBRT. Toxicities were graded using Common Terminology Criteria for Adverse Events ( …
METHODS AND MATERIALS: This was a single-center randomized trial in patients with intermediate- and high-risk localized prostate cancer who …
Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy.
Saadipoor A, Razzaghdoust A, Simforoosh N, Mahdavi A, Bakhshandeh M, Moghadam M, Abdollahi H, Mofid B. Saadipoor A, et al. Phytother Res. 2019 Feb;33(2):370-378. doi: 10.1002/ptr.6230. Epub 2018 Nov 14. Phytother Res. 2019. PMID: 30427093 Clinical Trial.
Acute toxicities including proctitis and cystitis were assessed weekly during the treatment and once thereafter using CTCAE v.4.03 grading criteria. ...The patients undergoing definitive RT were followed to evaluate the tumor response. Nanocurcumin was well t …
Acute toxicities including proctitis and cystitis were assessed weekly during the treatment and once thereafter using CTCAE v. …
68Ga-PSMA-PET/CT-directed IGRT/SBRT for oligometastases of recurrent prostate cancer after initial surgery.
Marzec J, Becker J, Paulsen F, Wegener D, Olthof SC, Pfannenberg C, Schwenck J, Bedke J, Stenzl A, Nikolaou K, la Fougère C, Zips D, Müller AC. Marzec J, et al. Acta Oncol. 2020 Feb;59(2):149-156. doi: 10.1080/0284186X.2019.1669816. Epub 2019 Sep 27. Acta Oncol. 2020. PMID: 31559880
Mean PSA (Prostate-specific antigen)-level at time of imaging reached 2.2 ng/mL (range 0.2-10.1). PET/CT-positive lesions were treated with different fractionation schedules reaching biological equivalent doses (BED) of 116.7-230.0 Gy. ...A PSA-decline (50%) …
Mean PSA (Prostate-specific antigen)-level at time of imaging reached 2.2 ng/mL (range 0.2-10.1). PET/CT-positive lesio …
Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma.
Jia AY, Narang A, Safar B, Zaheer A, Murphy A, Azad NS, Gearhart S, Fang S, Efron J, Warczynski T, Hacker-Prietz A, Meyer J. Jia AY, et al. Radiat Oncol. 2019 Aug 19;14(1):147. doi: 10.1186/s13014-019-1358-1. Radiat Oncol. 2019. PMID: 31426827 Free PMC article. Clinical Trial.
Twenty patients underwent surgical resection; pathologic complete response was observed in seven (35%) of these twenty. The main radiation-associated toxicity was proctitis with CTCAE Grade 2 proctitis observed in seven patients (27%). Post-oper …
Twenty patients underwent surgical resection; pathologic complete response was observed in seven (35%) of these twenty. The main radiation-a …
18 results